| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Lex M. Bouter | Q38328273 |
| P2093 | author name string | Servaas A Morré | |
| Chris J L M Meijer | |||
| Adriaan J C van den Brule | |||
| Irene G M van Valkengoed | |||
| A Joan P Boeke | |||
| P433 | issue | 2 | |
| P921 | main subject | Chlamydia trachomatis | Q131065 |
| cost-effectiveness analysis | Q1754768 | ||
| P304 | page(s) | 416-425 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | International Journal of Epidemiology | Q6051393 |
| P1476 | title | Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses | |
| P478 | volume | 33 |
| Q37838564 | 2015 UK national guideline for the management of infection with Chlamydia trachomatis |
| Q24813686 | Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice |
| Q37846961 | Advances in sampling and screening for chlamydia |
| Q37838405 | Background review for the '2015 European guideline on the management of Chlamydia trachomatis infections'. |
| Q36381197 | Bayesian methods for evidence synthesis in cost-effectiveness analysis |
| Q37608361 | Chlamydia in gynecologic practice. |
| Q37836151 | Chlamydia sequelae cost estimates used in current economic evaluations: does one-size-fit-all? |
| Q37836043 | Chlamydia trachomatis as the Cause of Infectious Infertility: Acute, Repetitive or Persistent Long-Term Infection? |
| Q37834018 | Chlamydia trachomatis infections of the female genital tract: state of the art. |
| Q35071155 | Chlamydia trachomatis vaccine research through the years |
| Q37835246 | Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women |
| Q37006193 | Costs and health consequences of chlamydia management strategies among pregnant women in sub-Saharan Africa |
| Q24600049 | Current knowledge of the aetiology of human tubal ectopic pregnancy |
| Q35588491 | Differences in growth characteristics and elementary body associated cytotoxicity between Chlamydia trachomatis oculogenital serovars D and H and Chlamydia muridarum |
| Q37849196 | Distribution of Chlamydia trachomatis serotypes in clinical urogenital samples from north-eastern Croatia. |
| Q34352823 | Ectopic pregnancy: a review |
| Q37614736 | Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. |
| Q37835498 | Evaluation of screening for Chlamydia trachomatis among young women in primary health care services in Manaus, Amazonas State, Brazil |
| Q36359124 | Evidence synthesis, parameter correlation and probabilistic sensitivity analysis |
| Q36129347 | Genital tract lesions in sexually mature Göttingen minipigs during the initial stages of experimental vaginal infection with Chlamydia trachomatis serovar D. |
| Q43415644 | Has the incidence of pelvic inflammatory disease following chlamydial infection been overestimated? |
| Q37849038 | Hospital-diagnosed late sequelae after female Chlamydia trachomatis infections in 1990-2006 in Turku, Finland |
| Q37419766 | Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis |
| Q34754603 | Impact of Chlamydia trachomatis in the reproductive setting: British Fertility Society Guidelines for practice |
| Q36958201 | Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study |
| Q35026625 | Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges. |
| Q40028428 | Multiparameter evidence synthesis in epidemiology and medical decision-making |
| Q35148159 | Pathogenesis of genital tract disease due to Chlamydia trachomatis |
| Q55400741 | Pathway-Wide Genetic Risks in Chlamydial Infections Overlap between Tissue Tropisms: A Genome-Wide Association Scan. |
| Q50319378 | Population-based analysis of ocular Chlamydia trachomatis in trachoma-endemic West African communities identifies genomic markers of disease severity. |
| Q34433420 | Reconceptualizing the chlamydial inclusion as a pathogen-specified parasitic organelle: an expanded role for Inc proteins |
| Q64133298 | Relation between infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a Dutch cohort of women previously tested for chlamydia in a chlamydia screening trial |
| Q37055567 | Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model |
| Q36491361 | Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling |
| Q37833827 | Sexually transmitted infections: challenges ahead |
| Q33743408 | Steroids alone or as adjunctive therapy with doxycycline fail to improve oviduct damage in mice infected with Chlamydia muridarum |
| Q36343688 | The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women. |
| Q37006317 | The cost effectiveness of opportunistic chlamydia screening in England. |
| Q36721366 | The importance of chlamydial infections in obstetrics and gynaecology: an update |
Search more.